Cargando…
Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-indu...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562873/ https://www.ncbi.nlm.nih.gov/pubmed/31075907 http://dx.doi.org/10.3390/cancers11050642 |
_version_ | 1783426422786752512 |
---|---|
author | Kim, Jung Lim Kim, Bo Ram Kim, Dae Yeong Jeong, Yoon A. Jeong, Soyeon Na, Yoo Jin Park, Seong Hye Yun, Hye Kyeong Jo, Min Jee Kim, Bu Gyeom Kim, Han Do Kim, Dae Hyun Oh, Sang Cheul Lee, Sun Il Lee, Dae-Hee |
author_facet | Kim, Jung Lim Kim, Bo Ram Kim, Dae Yeong Jeong, Yoon A. Jeong, Soyeon Na, Yoo Jin Park, Seong Hye Yun, Hye Kyeong Jo, Min Jee Kim, Bu Gyeom Kim, Han Do Kim, Dae Hyun Oh, Sang Cheul Lee, Sun Il Lee, Dae-Hee |
author_sort | Kim, Jung Lim |
collection | PubMed |
description | Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-inducing ligand (TRAIL) produces synergistic antitumor effects in vitro. However, this synergistic effect was not observed in normal colonic cells. The levels of ER stress-related proteins, including C/EBP homologous protein (CHOP) and phosphorylated protein kinase RNA-like ER kinase (PERK) were increased in treatment of cannabidiol. Cannabidiol enhanced significantly DR5 expression by ER stress. Knockdown of DR5 decreased the combined effect of cannabidiol and TRAIL. Additionally, the combination of TRAIL and cannabidiol decreased tumor growth in xenograft models. Our studies demonstrate that cannabidiol enhances TRAIL-induced apoptosis by upregulating DR5 and suggests that cannabidiol is a novel agent for increasing sensitivity to TRAIL. |
format | Online Article Text |
id | pubmed-6562873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65628732019-06-17 Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer Kim, Jung Lim Kim, Bo Ram Kim, Dae Yeong Jeong, Yoon A. Jeong, Soyeon Na, Yoo Jin Park, Seong Hye Yun, Hye Kyeong Jo, Min Jee Kim, Bu Gyeom Kim, Han Do Kim, Dae Hyun Oh, Sang Cheul Lee, Sun Il Lee, Dae-Hee Cancers (Basel) Article Cannabidiol, a major non-psychotomimetic compound derived from Cannabis sativa, is a potential therapeutic agent for a variety of diseases such as inflammatory diseases, chronic neurodegenerative diseases, and cancers. Here, we found that the combination of cannabidiol and TNF-related apoptosis-inducing ligand (TRAIL) produces synergistic antitumor effects in vitro. However, this synergistic effect was not observed in normal colonic cells. The levels of ER stress-related proteins, including C/EBP homologous protein (CHOP) and phosphorylated protein kinase RNA-like ER kinase (PERK) were increased in treatment of cannabidiol. Cannabidiol enhanced significantly DR5 expression by ER stress. Knockdown of DR5 decreased the combined effect of cannabidiol and TRAIL. Additionally, the combination of TRAIL and cannabidiol decreased tumor growth in xenograft models. Our studies demonstrate that cannabidiol enhances TRAIL-induced apoptosis by upregulating DR5 and suggests that cannabidiol is a novel agent for increasing sensitivity to TRAIL. MDPI 2019-05-09 /pmc/articles/PMC6562873/ /pubmed/31075907 http://dx.doi.org/10.3390/cancers11050642 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Jung Lim Kim, Bo Ram Kim, Dae Yeong Jeong, Yoon A. Jeong, Soyeon Na, Yoo Jin Park, Seong Hye Yun, Hye Kyeong Jo, Min Jee Kim, Bu Gyeom Kim, Han Do Kim, Dae Hyun Oh, Sang Cheul Lee, Sun Il Lee, Dae-Hee Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title_full | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title_fullStr | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title_full_unstemmed | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title_short | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
title_sort | cannabidiol enhances the therapeutic effects of trail by upregulating dr5 in colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562873/ https://www.ncbi.nlm.nih.gov/pubmed/31075907 http://dx.doi.org/10.3390/cancers11050642 |
work_keys_str_mv | AT kimjunglim cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT kimboram cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT kimdaeyeong cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT jeongyoona cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT jeongsoyeon cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT nayoojin cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT parkseonghye cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT yunhyekyeong cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT jominjee cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT kimbugyeom cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT kimhando cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT kimdaehyun cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT ohsangcheul cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT leesunil cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer AT leedaehee cannabidiolenhancesthetherapeuticeffectsoftrailbyupregulatingdr5incolorectalcancer |